Published in Lancet Neurol on October 30, 2013
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet (2014) 2.88
Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. Nature (2014) 2.10
Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol (2015) 1.82
The SKIV2L RNA exosome limits activation of the RIG-I-like receptors. Nat Immunol (2014) 1.73
Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest (2014) 1.50
Aicardi-Goutières syndrome is caused by IFIH1 mutations. Am J Hum Genet (2014) 1.41
Neuroradiologic patterns and novel imaging findings in Aicardi-Goutières syndrome. Neurology (2015) 1.41
The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol (2017) 1.38
Type I interferon in the pathogenesis of lupus. J Immunol (2014) 1.29
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J Clin Invest (2014) 1.25
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A (2015) 1.17
Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J (2014) 1.07
Ribonuclease H2 mutations induce a cGAS/STING-dependent innate immune response. EMBO J (2016) 1.04
The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition. PLoS Genet (2015) 0.97
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome. Elife (2015) 0.96
Human disease phenotypes associated with mutations in TREX1. J Clin Immunol (2015) 0.93
Advances in understanding the role of type I interferons in systemic lupus erythematosus. Curr Opin Rheumatol (2014) 0.93
Activation and regulation of DNA-driven immune responses. Microbiol Mol Biol Rev (2015) 0.92
Targeting of type I interferon in systemic autoimmune diseases. Transl Res (2014) 0.92
Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. J Clin Invest (2015) 0.90
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs. Front Immunol (2015) 0.90
TREM2 in CNS homeostasis and neurodegenerative disease. Mol Neurodegener (2015) 0.89
Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview. J Exp Med (2016) 0.86
Type I interferon dysregulation and neurological disease. Nat Rev Neurol (2015) 0.84
Identification of host proteins interacting with the integrin-like A domain of Toxoplasma gondii micronemal protein MIC2 by yeast-two-hybrid screening. Parasit Vectors (2014) 0.82
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL. Neurol Neuroimmunol Neuroinflamm (2014) 0.82
Animal Models of Interferon Signature Positive Lupus. Front Immunol (2015) 0.81
RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA. Nat Commun (2016) 0.80
Type I interferonopathies in pediatric rheumatology. Pediatr Rheumatol Online J (2016) 0.80
Type I interferonopathies--an expanding disease spectrum of immunodysregulation. Semin Immunopathol (2015) 0.79
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature. Blood (2016) 0.79
Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside. Pediatr Rheumatol Online J (2014) 0.79
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease. J Clin Immunol (2016) 0.79
Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. J Exp Med (2017) 0.78
Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J Exp Med (2017) 0.77
Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications. Ther Adv Musculoskelet Dis (2015) 0.77
Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey. J Clin Immunol (2016) 0.77
Newly recognized Mendelian disorders with rheumatic manifestations. Curr Opin Rheumatol (2015) 0.76
Identification of Candidate Predictors of Lupus Flare. Trans Am Clin Climatol Assoc (2015) 0.76
Negative regulators of the RIG-I-like receptor signaling pathway. Eur J Immunol (2017) 0.76
RNA Editing, ADAR1, and the Innate Immune Response. Genes (Basel) (2017) 0.75
Neuromyelitis optica in a child with Aicardi-Goutières syndrome. Neurology (2015) 0.75
Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus. J Mol Med (Berl) (2016) 0.75
Ubiquitin-dependent Turnover of Adenosine Deaminase Acting on RNA 1 (ADAR1) Is Required for Efficient Antiviral Activity of Type I Interferon. J Biol Chem (2016) 0.75
Characterisation of Aicardi-Goutières syndrome. Lancet Neurol (2013) 0.75
Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2? Dev Med Child Neurol (2017) 0.75
Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation. Clin Rheumatol (2017) 0.75
Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci (1957) 13.46
A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 12.86
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A (2003) 11.65
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med (2003) 11.23
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet (2006) 6.15
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet (2009) 5.84
Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet (2006) 5.26
Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum (2005) 4.84
Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet (2009) 3.07
Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet (2007) 2.81
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet (2012) 2.63
Studies on the production, mode of action and properties of interferon. Br J Exp Pathol (1957) 2.61
A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol (1984) 2.51
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum (2006) 2.50
Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature (1974) 2.10
Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study. Arthritis Rheum (2013) 2.06
Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp (2009) 1.93
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis (2011) 1.91
Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes. Nat Immunol (2012) 1.83
Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci (2011) 1.81
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. Arthritis Rheum (2010) 1.77
Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy. J Neurol Sci (1988) 1.67
Lethality of interferon preparations for newborn mice. Nature (1975) 1.65
Aicardi-Goutières syndrome: an update and results of interferon-alpha studies. Ann Neurol (1998) 1.61
Progressive glomerulonephritis in mice treated with interferon preparations at birth. Nature (1976) 1.59
Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasis. Dev Med Child Neurol (2010) 1.47
Phenotypic overlap between infantile systemic lupus erythematosus and Aicardi-Goutières syndrome. Neuropediatrics (2005) 1.41
Systemic lupus erythematosus or Aicardi-Goutières syndrome? Neuropediatrics (2000) 1.37
Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology (1998) 1.34
Evolutionary genetic dissection of human interferons. J Exp Med (2011) 1.32
The Aicardi-Goutières syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). J Med Genet (1995) 1.28
Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus. Hum Genomics Proteomics (2009) 1.22
Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study. Arthritis Rheum (2012) 1.21
Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid. Arthritis Rheum (2013) 1.13
Early intrathecal synthesis of interferon in herpes encephalitis. Biomedicine (1979) 1.12
Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood (2008) 1.12
Cerebral vasculopathy is a common feature in Aicardi-Goutieres syndrome associated with SAMHD1 mutations. Proc Natl Acad Sci U S A (2011) 1.08
Interferon and Aicardi-Goutières syndrome. Eur J Paediatr Neurol (2002) 1.07
Therapies in Aicardi-Goutières syndrome. Clin Exp Immunol (2014) 1.07
Endogenous retroelements and autoimmune disease. Curr Opin Immunol (2012) 1.06
Interferon-induced disease in mice and rats. Ann N Y Acad Sci (1980) 1.06
Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors. Eur Cytokine Netw (2007) 0.94
Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus. Ann Rheum Dis (2011) 0.93
The role of interferon in immediate hypersensitivity and autoimmune diseases. Ann N Y Acad Sci (1980) 0.90
Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice. Clin Exp Immunol (2013) 0.85
Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science (2011) 6.19
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet (2006) 6.15
TLR3 deficiency in patients with herpes simplex encephalitis. Science (2007) 5.86
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet (2009) 5.84
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature (2011) 5.28
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet (2006) 5.26
ASPM is a major determinant of cerebral cortical size. Nat Genet (2002) 4.57
Herpes simplex virus encephalitis in human UNC-93B deficiency. Science (2006) 4.26
Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science (2008) 4.04
Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 4.02
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med (2010) 3.98
Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome. Nat Genet (2006) 3.97
Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet (2003) 3.96
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med (2010) 3.93
Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest (2009) 3.89
Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet (2005) 3.84
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med (2011) 3.63
Identification of microcephalin, a protein implicated in determining the size of the human brain. Am J Hum Genet (2002) 3.13
TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Nat Genet (2011) 3.06
Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med (2011) 2.93
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest (2010) 2.92
Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol (2010) 2.87
Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet (2007) 2.81
Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet (2007) 2.73
Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat Genet (2009) 2.72
Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis (2002) 2.71
Clinical and molecular genetics of Leber's congenital amaurosis: a multicenter study of Italian patients. Invest Ophthalmol Vis Sci (2007) 2.69
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med (2007) 2.64
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet (2012) 2.63
Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum (2013) 2.60
Meiotic and epigenetic defects in Dnmt3L-knockout mouse spermatogenesis. Proc Natl Acad Sci U S A (2005) 2.56
Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome. Am J Clin Pathol (2011) 2.50
Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. Arthritis Rheum (2010) 2.50
Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity (2010) 2.47
Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity (2007) 2.42
A de novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum. Am J Hum Genet (2013) 2.42
De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet (2012) 2.34
Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol (2003) 2.29
tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat Genet (2008) 2.28
The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression. EMBO Rep (2008) 2.22
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler (2013) 2.20
Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain (2010) 2.19
X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med (2006) 2.18
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood (2013) 2.18
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep (2011) 2.17
Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity (2005) 2.16
Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat Genet (2011) 2.16
Skin markers of occult spinal dysraphism in children: a review of 54 cases. Arch Dermatol (2004) 2.16
Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood (2003) 2.11
Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. Am J Hum Genet (2010) 2.08